Record No:1


ACCESS NOD114440
GENE_NAMEEZH2
DESCRIPTIONEnhancer of zeste 2 polycomb repressive complex 2 subunit
ALIASESENX-1, ENX1, EZH2b, KMT6, KMT6A, WVS, WVS2.
NCBI_ENTREZ_NO2146
UNIPROT_ACCESS_NOQ15910
ORGANISMHuman
DISEASE_PHENOTYPEAllergic Rhinitis
SAMPLEPeripheral Blood Mononuclear Cells (PBMCs)
TECHNIQUESFlow Cytometry
OMICSOthers
STUDYLow Throughput
GEO_PRIDE_ACCESS_NONA
COMMENTSEZH2 expression was significantly decreased in allergic rhinitis patients as compared to healthy controls.
REFERENCE28740493
IMMUNITY_TERMNo
GO_MOLECULAR_FUNCTIONRNA polymerase II proximal promoter sequence-specific DNA binding, RNA polymerase II core promoter sequence-specific DNA binding, DNA-binding transcription factor activity (RNA polymerase II-specific), DNA binding, chromatin binding, transcription corepressor activity, RNA binding, protein binding, methyltransferase activity, protein-lysine N-methyltransferase activity, transferase activity, histone-lysine N-methyltransferase activity, chromatin DNA binding, histone methyltransferase activity, ribonucleoprotein complex binding, sequence-specific DNA binding, transcription regulatory region DNA binding, histone methyltransferase activity (H3-K27 specific), primary miRNA binding, promoter-specific chromatin binding.
GO_BIOLOGICAL_PROCESSNegative regulation of transcription by RNA polymerase II, regulation of protein phosphorylation, DNA methylation, chromatin organization, chromatin silencing at telomere, regulation of DNA-templated transcription,, regulation of transcription by RNA polymerase II, positive regulation of cell proliferation, regulation of gene expression, negative regulation of gene expression, positive regulation of epithelial to mesenchymal transition, regulation of gliogenesis, skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration, cardiac muscle hypertrophy in response to stress, histone methylation, cerebellar cortex development, hippocampus development, methylation, response to estradiol, negative regulation of transcription elongation from RNA polymerase II promoter, histone lysine methylation, cellular response to trichostatin A, hepatocyte homeostasis, regulation of cell proliferation, regulation of circadian rhythm, positive regulation of MAP kinase activity, negative regulation of DNA-binding transcription factor activity, positive regulation of GTPase activity, negative regulation of epidermal cell differentiation, negative regulation of gene expression, epigenetic, negative regulation of transcription, DNA-templated, negative regulation of retinoic acid receptor signaling pathway, rhythmic process, regulation of neurogenesis, negative regulation of striated muscle cell differentiation, cellular response to hydrogen peroxide, G1 to G0 transition, negative regulation of G0 to G1 transition, histone H3-K27 methylation, protein localization to chromatin, positive regulation of protein serine/threonine kinase activity, liver regeneration, histone H3-K27 trimethylation, positive regulation of dendrite development, positive regulation of cell cycle G1/S phase transition, response to tetrachloromethane, negative regulation of G1/S transition of mitotic cell cycle.
BIOGRID_INTERACTION_ID108446
SNP_ID-
DRUG_ID-
STRUCTURE_ID204240
204241
MONOCLONAL_ANTIBODYAnti-KMT6 / EZH2 antibody for Human, Rat, Mouse; Anti-KMT6 / EZH2 - N terminal antibody for Human, Rat, Mouse; Anti-KMT6 / EZH2 - C terminal antibody for Human, Mouse.